Clinical Trial Update: A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing letrozole plus megestrol acetate vs letrozole alone as a pre-operative window study in postmenopausal ER-positive breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED